Harimoto Norifumi, Yoshizumi Tomoharu, Sakata Kazuhito, Nagatsu Akihisa, Motomura Takashi, Itoh Shinji, Harada Noboru, Ikegami Toru, Uchiyama Hideaki, Soejima Yuji, Maehara Yoshihiko
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
World J Surg. 2017 Nov;41(11):2805-2812. doi: 10.1007/s00268-017-4097-1.
The Controlling Nutritional Status (CONUT) score is an objective tool widely used to assess nutritional status in patients with inflammatory disease, chronic heart failure, and chronic liver disease. The relationship between CONUT score and prognosis in patients who have undergone hepatic resection, however, has not been evaluated.
Data were retrospectively collected for 357 consecutive patients with hepatocellular carcinoma (HCC) who had undergone hepatic resection with curative intent between January 2004 and December 2015. The patients were assigned to two groups, those with preoperative CONUT scores ≤3 (low CONUT score) and >3 (high CONUT score), and their clinicopathological characteristics, surgical outcomes, and long-term survival were compared.
Of the 357 patients, 69 (19.3%) had high (>3) and 288 (80.7%) had low (≤3) preoperative CONUT scores. High CONUT score was significantly associated with HCV infection, low serum albumin and cholesterol concentrations, low lymphocyte count, shorter prothrombin time, Child-Pugh B and liver damage B scores, and blood transfusion. Multivariate analysis identified six factors prognostic of poor overall survival (older age, liver damage B score, high CONUT score, poor tumor differentiation, the presence of intrahepatic metastases, and blood transfusion) and five factors prognostic of reduced recurrence-free survival (older age, higher ICGR15, larger tumor size, presence of intrahepatic metastasis, and blood transfusion).
In patients with HCC, preoperative CONUT scores are predictive of poorer overall survival, even after adjustments for other known predictors.
控制营养状态(CONUT)评分是一种广泛用于评估炎症性疾病、慢性心力衰竭和慢性肝病患者营养状态的客观工具。然而,CONUT评分与肝切除患者预后之间的关系尚未得到评估。
回顾性收集了2004年1月至2015年12月期间连续357例接受根治性肝切除的肝细胞癌(HCC)患者的数据。将患者分为两组,术前CONUT评分≤3(低CONUT评分)和>3(高CONUT评分)的患者,比较他们的临床病理特征、手术结果和长期生存率。
357例患者中,69例(19.3%)术前CONUT评分高(>3),288例(80.7%)术前CONUT评分低(≤3)。高CONUT评分与丙型肝炎病毒感染、血清白蛋白和胆固醇浓度低、淋巴细胞计数低、凝血酶原时间短、Child-Pugh B级和肝损伤B级评分以及输血显著相关。多因素分析确定了六个总体生存不良的预后因素(年龄较大、肝损伤B级评分、高CONUT评分、肿瘤分化差、肝内转移的存在和输血)和五个无复发生存率降低的预后因素(年龄较大、ICGR15较高、肿瘤较大、肝内转移的存在和输血)。
在HCC患者中,即使在对其他已知预测因素进行调整后,术前CONUT评分仍可预测总体生存率较差。